메뉴 건너뛰기




Volumn 10, Issue 4, 2007, Pages 367-378

Impact of formulary management and step therapy for non-sedating antihistamines on prescription drug utilisation and costs

Author keywords

Formulary; Non sedating antihistamines; Pharmacy benefit management; Step therapy

Indexed keywords

ANTIHISTAMINIC AGENT; CETIRIZINE; DESLORATADINE; FEXOFENADINE; LORATADINE; PSEUDOEPHEDRINE;

EID: 38149000221     PISSN: 13696998     EISSN: None     Source Type: Journal    
DOI: 10.3111/13696990701640653     Document Type: Article
Times cited : (1)

References (28)
  • 1
    • 38149110806 scopus 로고    scopus 로고
    • National Institute for Health Care Management Research and Educational Foundation, Available at:, last accessed 15 June
    • National Institute for Health Care Management Research and Educational Foundation. Prescription drug expenditures in 2001: another year of escalating costs. Available at: http://www.nihcm.org/nihcmor/pdf/spending2001.pdf [last accessed 15 June 2007].
    • (2007) Prescription drug expenditures in 2001: Another year of escalating costs
  • 2
    • 0002567055 scopus 로고    scopus 로고
    • Three-tier copayment plans: Design considerations and effectiveness
    • Segedin DA. Three-tier copayment plans: design considerations and effectiveness. Drug Benefits Trends 1999; 11: 43-52.
    • (1999) Drug Benefits Trends , vol.11 , pp. 43-52
    • Segedin, D.A.1
  • 3
    • 0010642803 scopus 로고    scopus 로고
    • Three-tier copayment systems and consumer concentric care
    • Penna P. Three-tier copayment systems and consumer concentric care. Journal of Managed Care Pharmacy 2000; 6: 351-354.
    • (2000) Journal of Managed Care Pharmacy , vol.6 , pp. 351-354
    • Penna, P.1
  • 4
    • 0033658394 scopus 로고    scopus 로고
    • Allergic rhinitis: Epidemiology and natural history
    • Schoenwetter WF. Allergic rhinitis: epidemiology and natural history. Allergy and Asthma Proceedings 2000; 21: 1-6.
    • (2000) Allergy and Asthma Proceedings , vol.21 , pp. 1-6
    • Schoenwetter, W.F.1
  • 5
    • 38149078460 scopus 로고    scopus 로고
    • McCrory DC, Williams JW, Dolor RJ et al. Management of Allergic Rhinitis in the Working-Age Population. Agency for Healthcare Research and Quality (AHRQ), March Report No. 67. Washington, DC.
    • McCrory DC, Williams JW, Dolor RJ et al. Management of Allergic Rhinitis in the Working-Age Population. Agency for Healthcare Research and Quality (AHRQ), March Report No. 67. Washington, DC.
  • 8
    • 38149130896 scopus 로고    scopus 로고
    • and Drug Administration, Available at:, last accessed 15 June
    • US Food and Drug Administration. FDA approves OTC Claritin. Available at: http://www.fda.gov/bbs/topics/NEWS/2002/NEW00855.html [last accessed 15 June 2007].
    • (2007) FDA approves OTC Claritin
    • Food, U.S.1
  • 9
    • 38149051843 scopus 로고    scopus 로고
    • Drug Effectiveness Review Project. Drug class review on newer antihistamines
    • Oregon Health and Science University, Available at:, last accessed 15 June
    • Oregon Health and Science University. Drug Effectiveness Review Project. Drug class review on newer antihistamines. Final Report Update 1. Available at: http://www.ohsu.edu/drugeffectiveness/reports/final.cfm [last accessed 15 June 2007].
    • (2007) Final Report Update , vol.1
  • 10
    • 21044435814 scopus 로고    scopus 로고
    • The effect of Rx-to-OTC switch of loratadine and changes in prescription drug benefits on utilization and cost of therapy
    • Sullivan PW, Nair KV, Patel BV. The effect of Rx-to-OTC switch of loratadine and changes in prescription drug benefits on utilization and cost of therapy. American Journal of Managed Care 2005; 11: 374-382.
    • (2005) American Journal of Managed Care , vol.11 , pp. 374-382
    • Sullivan, P.W.1    Nair, K.V.2    Patel, B.V.3
  • 11
    • 0642367855 scopus 로고    scopus 로고
    • Transitioning the second-generation antihistamines to over-the-counter status: A cost-effectiveness analysis
    • Sullivan PW, Follin SL, Nichol MB. Transitioning the second-generation antihistamines to over-the-counter status: a cost-effectiveness analysis. Medical Care 2003; 41: 1382-1395.
    • (2003) Medical Care , vol.41 , pp. 1382-1395
    • Sullivan, P.W.1    Follin, S.L.2    Nichol, M.B.3
  • 12
    • 3843084916 scopus 로고    scopus 로고
    • The economic impact of payer policies after the Rx-to-OTC switch of second-generation antihistamines
    • Sullivan PW, Nichol MB. The economic impact of payer policies after the Rx-to-OTC switch of second-generation antihistamines. Value in Health 2004; 7: 402-412.
    • (2004) Value in Health , vol.7 , pp. 402-412
    • Sullivan, P.W.1    Nichol, M.B.2
  • 13
    • 0345731431 scopus 로고    scopus 로고
    • Therapeutic and economic consequences of the OTC conversion of loratadine
    • Nair KV, Sullivan PW. Therapeutic and economic consequences of the OTC conversion of loratadine. Annals of Pharmacotherapy 2004; 38: 169-171.
    • (2004) Annals of Pharmacotherapy , vol.38 , pp. 169-171
    • Nair, K.V.1    Sullivan, P.W.2
  • 14
    • 33745488084 scopus 로고    scopus 로고
    • Evaluation of product switching after a state Medicaid program began covering loratadine OTC 1 year after market availability
    • Trygstad TK, Hansen RA, Wegner SE. Evaluation of product switching after a state Medicaid program began covering loratadine OTC 1 year after market availability. Journal of Managed Care Pharmacy 2006; 12: 108-120.
    • (2006) Journal of Managed Care Pharmacy , vol.12 , pp. 108-120
    • Trygstad, T.K.1    Hansen, R.A.2    Wegner, S.E.3
  • 15
    • 0037393305 scopus 로고    scopus 로고
    • Sedation and performance impairment of diphenhydramine and second-generation antihistamines: A meta-analysis
    • Bender BG, Berning S, Dudden R et al. Sedation and performance impairment of diphenhydramine and second-generation antihistamines: a meta-analysis. Journal of Allergy and Clinical Immunology 2003; 111: 770-776.
    • (2003) Journal of Allergy and Clinical Immunology , vol.111 , pp. 770-776
    • Bender, B.G.1    Berning, S.2    Dudden, R.3
  • 16
    • 0032928808 scopus 로고    scopus 로고
    • Comparative tolerability of second-generation antihistamines
    • Horak F, Stubner UP. Comparative tolerability of second-generation antihistamines. Drug Safety 1999; 20: 385-401.
    • (1999) Drug Safety , vol.20 , pp. 385-401
    • Horak, F.1    Stubner, U.P.2
  • 17
    • 38149094667 scopus 로고    scopus 로고
    • Consumer Reports Best Buy Drugs. Treating allergies, hay fever, and hives: the antihistamines. Available at: http://www.crbestbuydrugs.org/ drugreport_DR_Antihis.shtml [last accessed 15 June 2007].
    • Consumer Reports Best Buy Drugs. Treating allergies, hay fever, and hives: the antihistamines. Available at: http://www.crbestbuydrugs.org/ drugreport_DR_Antihis.shtml [last accessed 15 June 2007].
  • 18
    • 38149110216 scopus 로고    scopus 로고
    • Pharmacy Benefit Insider. MCOs promote OTC loratadine, make formulary changes. Managed Pharmaceutical Report, March 2003. Available at: http://www.rxsolutions.com/c/pbi/pbi_view.asp?docid=322 [last accessed 15 June 2007].
    • Pharmacy Benefit Insider. MCOs promote OTC loratadine, make formulary changes. Managed Pharmaceutical Report, March 2003. Available at: http://www.rxsolutions.com/c/pbi/pbi_view.asp?docid=322 [last accessed 15 June 2007].
  • 19
    • 0041857027 scopus 로고    scopus 로고
    • Kaiser Family Foundation, Kaiser Family Foundation Menlo Park, CA
    • Kaiser Family Foundation. 2002 Employer Health Benefits Survey. Kaiser Family Foundation Menlo Park, CA, 2002.
    • (2002) Employer Health Benefits Survey
  • 20
    • 3242783295 scopus 로고    scopus 로고
    • Plan-sponsor savings and member experience with point-of-service prescription step therapy
    • Motheral BR, Henderson R, Cox ER. Plan-sponsor savings and member experience with point-of-service prescription step therapy. American Journal of Managed Care 2004; 10: 457-464.
    • (2004) American Journal of Managed Care , vol.10 , pp. 457-464
    • Motheral, B.R.1    Henderson, R.2    Cox, E.R.3
  • 21
    • 34248372565 scopus 로고    scopus 로고
    • Outcomes of sword swallowing and pharmaceutical step-therapy interventions
    • Curtiss FR. Outcomes of sword swallowing and pharmaceutical step-therapy interventions. Journal of Managed Care Pharmacy 2007; 13: 284-286.
    • (2007) Journal of Managed Care Pharmacy , vol.13 , pp. 284-286
    • Curtiss, F.R.1
  • 22
    • 34248356441 scopus 로고    scopus 로고
    • Assessing step-therapy programs: A step in the right direction
    • Gleason PP. Assessing step-therapy programs: a step in the right direction. Journal of Managed Care Pharmacy 2007; 13: 273-275.
    • (2007) Journal of Managed Care Pharmacy , vol.13 , pp. 273-275
    • Gleason, P.P.1
  • 23
    • 33746454327 scopus 로고    scopus 로고
    • Utilization and drug cost outcomes of a step-therapy edit for generic antidepressants in an HMO in an integrated health system
    • Dunn JD, Cannon HE, Mitchell MP et al. Utilization and drug cost outcomes of a step-therapy edit for generic antidepressants in an HMO in an integrated health system. Journal of Managed Care Pharmacy 2006; 12: 294-302.
    • (2006) Journal of Managed Care Pharmacy , vol.12 , pp. 294-302
    • Dunn, J.D.1    Cannon, H.E.2    Mitchell, M.P.3
  • 24
    • 34248328405 scopus 로고    scopus 로고
    • Effects of a step-therapy program forangiotensin receptor blockers on antihypertensive medication utilization patterns and cost of drug therapy
    • Yokoyama K, Yang W, Preblick R, et al. Effects of a step-therapy program forangiotensin receptor blockers on antihypertensive medication utilization patterns and cost of drug therapy. Journal of Managed Care Pharmacy 2007; 13: 235-244.
    • (2007) Journal of Managed Care Pharmacy , vol.13 , pp. 235-244
    • Yokoyama, K.1    Yang, W.2    Preblick, R.3
  • 27
    • 0033112337 scopus 로고    scopus 로고
    • The effect of Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: The case of histamine2-receptor antagonists
    • Andrade SE, Gurwitz JH, Fish LS. The effect of Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of histamine2-receptor antagonists. Medical Care 1999; 37: 424-430.
    • (1999) Medical Care , vol.37 , pp. 424-430
    • Andrade, S.E.1    Gurwitz, J.H.2    Fish, L.S.3
  • 28
    • 0027297012 scopus 로고
    • Loratadine and terfenadine in perennial allergic rhinitis. Treatment of nonresponders to the one drug with the other drug
    • Carlsen KH, Kramer J, Fagertun HE et al. Loratadine and terfenadine in perennial allergic rhinitis. Treatment of nonresponders to the one drug with the other drug. Allergy 1993; 48: 431-436.
    • (1993) Allergy , vol.48 , pp. 431-436
    • Carlsen, K.H.1    Kramer, J.2    Fagertun, H.E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.